common side effects of avandamet
upper respiratory tract infection
diarrhea
other side effects
anemia
comprehensive list of adverse effects
reported adverse reports
upper respiratory tract infections
injury
headache
metformin-rosiglitazone
hypoglycemia common
hypercholesterolemia
hyperlipidemiauncommon
weight gainrosiglitazone
hypoglycemia
hypercholesterolemia
weight gainfrequency
increases in waist
hip circumferencemetformin
hypoglycemia
lactic acidosis
mechanism of weight gain
combination of fluid retention
fat accumulation
adopt
monotherapy trial
median weight change with rosiglitazone at years
kg
metformin
weight loss of kg
drug-naive patients
overall change in median weight
clinical trials
major adverse cardiovascular events
overall data from rosiglitazone
long-term trials
record
adopt
dream trials
rosiglitazone n
control n =-rrb-
difference in overall mortality
major adverse cardiovascular events
meta-analysis of shorter-term trials
risk for myocardial infarction with rosiglitazone
placebo
record trial
rosiglitazone
cardiac outcomes
regulation of glycemia in diabetes
age years
male
significant difference in cardiovascular hospitalization
cardiovascular death
primary outcome
patients with type diabetes
receiving rosiglitazone
add-on therapy
n =-rrb-
active control
n =-rrb-
significant difference in the incidence of chf
secondary endpoint
trial
patients
failed metformin
sulfonylurea monotherapy
add-on rosiglitazone
active control
add-on metformin for those
sulfonylurea
add-on sulfonylurea for those
metformin
patients
target
glycosylated hemoglobin
hbac
heart failure
patients
receiving add-on rosiglitazone
patients
receiving active control
retrospective analysis of clinical trials
duration months
rosiglitazone
increased risk of myocardial ischemia
placebo control
events
angina pectoris
angina dyspnea
myocardial infarction
coronary thrombosis
myocardial ischemia
coronary artery disease
coronary artery disorder
increased risk with combination insulin therapy
patients
receiving nitrates for known coronary heart disease
cardiovascular events in patients with nyha class i
ii heart failure
increased risk of cardiovascular events
week trial in patients with nyha class i
ii heart failure
receiving rosiglitazone
n =-rrb-
placebo
n =-rrb-
events
cardiovascular deaths
worsening chf
worsening edema
worsening dyspnea
chf medication
cardiovascular hospitalization
edema
dose-related edema
rosiglitazone
clinical trials
healthy volunteers
receiving rosiglitazone mg
weeks
significant increase in median plasma volume
placebo
patients with inadequate glycemic control on diet
exercise
n =-rrb-
edema
patients
combination rosiglitazone/metformin
starting on rosiglitazone
metformin
concomitant administration with insulin
edema
higher frequency in the rosiglitazone
insulin combination trials
insulin
rosiglitazone with insulin
reports of new onset
exacerbation of chf
rate
insulin
mg
mg
insulin in combination with rosiglitazone
coadministration of rosiglitazone
insulin
edema
hypertension frequency
cardiovascular deaths
congestive heart failure
chf
myocardial infarction
angina
angina pectoris
angina dyspnea
myocardial infarction
coronary thrombosis
myocardial ischemia
coronary artery disease
coronary artery disorder
patients
rosiglitazone monotherapy
rosiglitazone/metformin combination treatment
anemia
n =-rrb- of patients
n =-rrb-
n =-rrb- of patient
receiving rosiglitazone
metformin monotherapy
lower pretreatment hemoglobin/hematocrit levels in patients
receiving combination therapy
higher reporting rate
laboratory findings
shown dose-related decreases in hemoglobin
hematocrit in patients
receiving rosiglitazone
decreases of g/dl
hemoglobin
hematocrit
changes
first months
following
dose increase
increased plasma volume
metformin-rosiglitazone
anemia
metformin
anemiavery
subnormal vitamin b levelsrosiglitazone
anemiafrequency
decrease in wbc counts
nausea/vomiting
diarrhea
dyspepsia
abdominal pain
loose stools
constipation
flatulence
gastritisuncommon
anorexiaside effects
nausea
anorexia
metallic taste
diarrhea
dyspepsia
flatulence
abdominal pain
diarrhea
patients in clinical trials
upper
respiratory tract infection
nasopharyngitis
sinusitis
bronchitis
coughing
pharyngitisrosiglitazone
frequency
dyspneapostmarketing reports
pulmonary edema
pleural effusions
rosiglitazone
postmarketing reports
anaphylactic reaction
urticaria
angioedema
rosiglitazone
postmarketing reports
diabetic
macular edema
decreased visual acuity
large long-term rosiglitazone
clinical trials
increased incidence of bone fracture in patients
receiving rosiglitazone
combination with sulfonylureas
metformin
incidence
first year
majority of fractures
women
upper arm
hand
foot
arthralgia common
pain
arthritisfrequency
fractures
metformin
mild erythemarosiglitazone
postmarketing reports
rash
pruritus
urticaria
angioedema
stevens-johnson syndrome
frequency
resumption of ovulation in premenopausal
anovulatory women
hormonal imbalance
urinary tract infection
rosiglitazone
hyperbilirubinemia
alt elevationspostmarketing reports
hepatitis
hepatic enzyme elevations
times
upper limit of normal
hepatic failure
viral infection
headaches
dizzinessmetformin
metallic tasterosiglitazone
frequency
stroke
injury common
fatigue
pain
pale skin
troubled breathing with exertion
unusual bleeding
bruising
unusual tiredness
weakness
anxiety
blurred vision
chest pain
discomfort
chills
cold sweats
coma
confusion
cool, pale skin
depression
dilated neck veins
dizziness
extreme fatigue
fast heartbeat
headache
increased hunger
irregular breathing
irregular heartbeat
nausea
nightmares
seizures
shakiness
slurred speech
swelling of the face
fingers
feet
lower legs
weight gain
stomach discomfort
decreased appetite
diarrhea
fast, shallow breathing
general feeling of discomfort
muscle pain
cramping
sleepiness
change in vision
dark urine
decreased urine output
hives
welts
itching
skin rash
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
pain
discomfort in the arms
jaw
neck
redness of the skin
stomach pain
sweating
vomiting
body aches
pain
cough
fever
sneezing
sore throat
difficulty with breathing
ear congestion
loss of voice
pain
tenderness around the eyes
cheekbones
runny nose
back pain
flu-like symptoms
difficulty with moving
pain in the joints